Back to search

Article

Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune Hepatitis

2021-11-01

Abstract excerpt

<h4>Background: </h4> Mycophenolate mofetil (MMF) is the most widely used second-line agent in auto-immune hepatitis (AIH). It is generally titrated up to patient response and continued for at least two years following complete liver enzyme normalization. However, in this maintenance phase individual dose adjustment to reach mycophenolic acid (MPA) exposure with the best benefit-risk probability may avoid adverse...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a9e902e-ceee-51fc-805b-207e09d9c9e6
DOI
10.22541/au.163577198.80163436/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Population Pharmacokinetics And Bayesian Estimation of Mycophenolate Mofetil In Patients With Autoimmune HepatitisDOI 10.22541/au.163577198.80163436/v1
Pharmacogenetics and Pharmacokinetics of Immunosuppressants: Clinical Correlations and Disease Activity Control in Egyptian Female Patients with Lupus Nephritis.Semantic proximity
Pharmacogenetics and pharmacokinetics of immunosuppressants: clinical correlations and disease activity control in Egyptian female patients with lupus nephritis.Semantic proximity
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.Semantic proximity
An integrated sampling strategy for therapeutic mycophenolic acid monitoring in lung transplant recipients.Semantic proximity
Population Pharmacokinetics and Dose Optimization of Tacrolimus in Chinese Adult Patients with Myasthenia GravisSemantic proximity
Pharmacokinetics and pharmacodynamics of mycophenolic acid in Nagase analbuminemic rats: Evaluation of protein binding effects using the modeling and simulation approach.Semantic proximity
Population PK/PD model of tacrolimus for exploring the relationship between accumulated exposure and quantitative scores in myasthenia gravis patients.Semantic proximity
Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.Semantic proximity
External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipientsSemantic proximity
Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.Semantic proximity
Parametric population pharmacokinetics of isoniazid: a systematic review.Semantic proximity
Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.Semantic proximity
Select a neighboring publication to make it the new centre.